Taxanes in the Treatment of Advanced Gastric Cancer

被引：16
作者：
Kang, Byung Woog [1 ]
Kwon, Oh-Kyoung [2 ]
Chung, Ho Young [2 ]
Yu, Wansik [2 ]
Kim, Jong Gwang [1 ]
机构：
[1] Kyungpook Natl Univ, Dept Oncol Hematol, Med Ctr, Sch Med,Canc Res Inst, 807 Hogukno, Daegu 41404, South Korea
[2] Kyungpook Natl Univ, Dept Surg, Kyungpook Natl Univ Hosp, Sch Med, Daegu 41494, South Korea
来源：
MOLECULES | 2016年 / 21卷 / 05期
基金：
新加坡国家研究基金会;
关键词：
gastric cancer; taxanes; paclitaxel; docetaxel; chemotherapy; PHASE-III TRIAL; ALBUMIN-BOUND PACLITAXEL; 2ND-LINE CHEMOTHERAPY; 1ST-LINE THERAPY; PLUS CISPLATIN; ANTITUMOR-ACTIVITY; OPEN-LABEL; FLUOROURACIL; DOCETAXEL; ADENOCARCINOMA;
D O I：
10.3390/molecules21050651
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Although rapid advances in treatment options have improved the prognosis of advanced gastric cancer (AGC), it remains a major public health problem and the second leading cause of cancer-related deaths in the world. Taxanes (paclitaxel and docetaxel) are microtubule stabilizing agents that inhibit the process of cell division, and have shown antitumor activity in the treatment of AGC as a single or combination chemotherapy. Accordingly, this review focuses on the efficacy and tolerability of taxanes in the first-or second-line chemotherapy setting for AGC.
引用
收藏
页数：10
相关论文
共 50 条
  • [41] Evolution of Taxanes in the Treatment of Metastatic Breast Cancer
    Binder, Sandra
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 9 - 14
  • [42] Efficacy of taxanes as adjuvant treatment of breast cancer: a review and meta-analysis of randomised clinical trials
    Gines, Jordi
    Sabater, Eliazar
    Martorell, Clara
    Grau, Maria
    Monroy, Marta
    Casado, Miguel A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (07) : 485 - 498
  • [43] Capecitabine in the treatment of advanced gastric cancer
    Lee, Jae-Lyun
    Kang, Yoon-Koo
    FUTURE ONCOLOGY, 2008, 4 (02) : 179 - 198
  • [44] Strategies to Decrease Taxanes Toxicities in the Adjuvant Treatment of Early Breast Cancer
    Tang, Shou-Ching
    CANCER INVESTIGATION, 2009, 27 (02) : 206 - 214
  • [45] Taxanes as a First-Line Systemic Treatment in Metastatic Breast Cancer
    Urquhart, Laura M.
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 15 - 21
  • [46] Breakthrough therapy for peritoneal carcinomatosis of gastric cancer:Intraperitoneal chemotherapy with taxanes
    Hironori Yamaguchi
    Joji Kitayama
    Hironori Ishigami
    Shinsuke Kazama
    Hiroaki Nozawa
    Kazushige Kawai
    Keisuke Hata
    Tomomichi Kiyomatsu
    Toshiaki Tanaka
    Junichiro Tanaka
    Takeshi Nishikawa
    Kensuke Otani
    Koji Yasuda
    Soichiro Ishihara
    Eiji Sunami
    Toshiaki Watanabe
    World Journal of Gastrointestinal Oncology, 2015, (11) : 285 - 291
  • [47] Breakthrough therapy for peritoneal carcinomatosis of gastric cancer: Intraperitoneal chemotherapy with taxanes
    Yamaguchi, Hironori
    Kitayama, Joji
    Ishigami, Hironori
    Kazama, Shinsuke
    Nozawa, Hiroaki
    Kawai, Kazushige
    Hata, Keisuke
    Kiyomatsu, Tomomichi
    Tanaka, Toshiaki
    Tanaka, Junichiro
    Nishikawa, Takeshi
    Otani, Kensuke
    Yasuda, Koji
    Ishihara, Soichiro
    Sunami, Eiji
    Watanabe, Toshiaki
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2015, 7 (11) : 285 - 291
  • [48] Pharmacoeconomic profile of taxanes in advanced ovarian cancer
    Messori, A
    Trippoli, S
    ANTI-CANCER DRUGS, 1998, 9 (10) : 909 - 916
  • [49] Taxanes in the Adjuvant Treatment of Early Breast Cancer, Emerging Consensus and Unanswered Questions
    Tang, Shou-Ching
    CANCER INVESTIGATION, 2009, 27 (05) : 489 - 495
  • [50] Taxanes in cancer treatment: Activity, chemoresistance and its overcoming
    Mosca, Luciana
    Ilari, Andrea
    Fazi, Francesco
    Assaraf, Yehuda G.
    Colotti, Gianni
    DRUG RESISTANCE UPDATES, 2021, 54
12345